Nalaganje...
Pioglitazone in Clinical Practice: Where Are We Now?
Pioglitazone, a thiazolidinedione, improves insulin sensitivity and thus reduces blood glucose. Clinical trials have suggested potential cardiovascular outcome benefits in association with pioglitazone; however, safety concerns are mounting, with recent data suggesting a link between pioglitazone an...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare Communications
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3508118/ https://ncbi.nlm.nih.gov/pubmed/22373598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-012-0001-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|